Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
17
×
boston
17
×
boston blog main
fda
17
×
life sciences
national blog main
boston top stories
clinical trials
deals
national top stories
investing
san francisco blog main
new york blog main
san diego blog main
san francisco top stories
startups
medical device
new york top stories
roche
san diego top stories
drugs
medical devices
perceptive advisors
venture capital
alexion pharmaceuticals
alnylam pharmaceuticals
biotech ipos
boston university
clinical trial
drug delivery
eli lilly
eventide asset management
genentech
hepatitis b
hereditary transthyretin amyloidosis
indiana blog main
ipo
medtronic
nonalcoholic steatohepatitis
novo nordisk
What
medicines
drug
million
company
developing
device
ipo
therapeutics
fda
medical
medicine
new
patients
pharmaceuticals
raised
roche
startup
treat
way
acquire
biotechs
blood
body
candidate
closed
deal
digital
disease
ipos
lead
muscle
pay
pharma
raises
research
rest
team
tests
time
absorb
Language
unset
unknown
Current search:
boston
×
biotech
×
fda
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine